Clinical guidelines for the use of antihypertensive drugs in perinatal hypertension

Title: Clinical guidelines for the use of antihypertensive drugs in perinatal hypertension
Edition: Original
Classification: Standard guideline
Field: Treatment
Countries and regions: China
Guidelines users: Obstetrician, cardiologist, clinical pharmacist
Evidence classification method: GRADE/ABCDE
Development unit: Chinese Society of Perinatal Medicine
Registration time: 2024-04-29
Registration number: PREPARE-2024CN598
Purpose of the guideline: Hypertensive disorder of pregnancy is a common complication in the perinatal period, and drug treatment is an important part of it. However, there are many antihypertensive drugs, and there is no consensus on the choice of drugs. The purpose of this guideline is to provide medical professionals with scientific treatment principles and drug recommendations, so as to safely and effectively manage hypertensive diseases during pregnancy and ensure the safety of mother and child.